Literature DB >> 1465038

Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse. A randomised, double-blind trial.

C Felding1, A L Mikkelsen, H V Clausen, A Loft, L G Larsen.   

Abstract

OBJECTIVE: To disclose a clinical and histopathological effect of local low-dose oestradiol treatment on the vagina.
DESIGN: A randomised, double-blind trial.
SETTING: Two gynaecological departments at University Hospitals.
SUBJECTS: Forty-eight postmenopausal women scheduled for surgery because of genital prolapse. INTERVENTION: 25 micrograms oestradiol or placebo, administered as vaginal pessaries daily, 3 weeks prior to surgery. MAIN OUTCOME MEASURES: Cytological, histological and clinical changes of the vaginal mucosa.
RESULTS: The thickness of the vaginal wall increased as did the oestrogenic index. No clinical effect was seen apart from decreased incidence of recurrent cystitis postoperatively.
CONCLUSIONS: Preoperative oestrogen treatment has been shown to reduce the incidence of recurrent cystitis and may be needed for stimulation of vaginal mucosa; the short-term clinical effect is not convincing, however.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465038     DOI: 10.1016/0378-5122(92)90208-l

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  9 in total

Review 1.  Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines.

Authors:  David D Rahn; Renée M Ward; Tatiana V Sanses; Cassandra Carberry; Mamta M Mamik; Kate V Meriwether; Cedric K Olivera; Husam Abed; Ethan M Balk; Miles Murphy
Journal:  Int Urogynecol J       Date:  2014-11-13       Impact factor: 2.894

Review 2.  Pearls and pitfalls of mesh surgery.

Authors:  Ajay Rane; Jay Iyer
Journal:  J Obstet Gynaecol India       Date:  2013-01-05

Review 3.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

4.  Ovariectomized mice and postmenopausal women exhibit analogous loss of genital epithelial integrity.

Authors:  Nirk E Quispe Calla; Rodolfo D Vicetti Miguel; Kristen M Aceves; Huijie Huang; Brooke Howitt; Thomas L Cherpes
Journal:  Tissue Barriers       Date:  2021-01-11

5.  Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review.

Authors:  Ginger D Constantine; Shelli Graham; Kate Lapane; Kathleen Ohleth; Brian Bernick; James Liu; Sebastian Mirkin
Journal:  Menopause       Date:  2019-07       Impact factor: 2.953

6.  Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study.

Authors:  M-L Marschalek; K Bodner; O Kimberger; S Zehetmayer; R Morgenbesser; W Dietrich; C Obruca; H Husslein; W Umek; H Koelbl; B Bodner-Adler
Journal:  BJOG       Date:  2021-09-21       Impact factor: 7.331

Review 7.  Local Estrogen Therapy for Pelvic Organ Prolapse in Postmenopausal Women: A Systematic Review and Meta-Analysis.

Authors:  Xia Yu; Li He; Yanjun Wang; Li Wang; Zhenglin Yang; Yonghong Lin
Journal:  Iran J Public Health       Date:  2022-08       Impact factor: 1.479

Review 8.  Local Oestrogen for Pelvic Floor Disorders: A Systematic Review.

Authors:  M A Weber; M H Kleijn; M Langendam; J Limpens; M J Heineman; J P Roovers
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

9.  Vaginal Dysbiosis from an Evolutionary Perspective.

Authors:  Natalia Schlabritz-Loutsevitch; Scott E Gygax; Edward Dick; William L Smith; Cathy Snider; Gene Hubbard; Gary Ventolini
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.